open access

Vol 26, No 1 (2019)
Letters to the Editors
Published online: 2019-03-14
Get Citation

The 18-fluorine-fluorodeoxyglucose positron-emission-tomography/computed tomography-guided treatment of prosthetic valve endocarditis

Grzegorz Sławiński, Ewa Lewicka, Maciej Kempa, Szymon Budrejko, Alicja Dąbrowska-Kugacka, Grzegorz Romanowicz, Grzegorz Raczak
DOI: 10.5603/CJ.2019.0017
·
Pubmed: 30882194
·
Cardiol J 2019;26(1):105-108.

open access

Vol 26, No 1 (2019)
Letters to the Editors
Published online: 2019-03-14

Abstract

Not available

Abstract

Not available
Get Citation
Supplementary Files (4)
Supplementary Figure 1. Chest X-ray showing the location of S-ICD and the epicardial VVI pacemaker.
View
2MB
Supplementary Figure 2. Intracardiac electrocardiogram presenting an inappropriate S-ICD shock.
View
179KB
Supplementary Figure 3. TTE showing progression of aortic regurgitation with the paravalvular leak.
View
65KB
Supplementary Table 1. The results of laboratory tests obtained during patient hospitalization in our department.
Download
16KB
About this article
Title

The 18-fluorine-fluorodeoxyglucose positron-emission-tomography/computed tomography-guided treatment of prosthetic valve endocarditis

Journal

Cardiology Journal

Issue

Vol 26, No 1 (2019)

Pages

105-108

Published online

2019-03-14

DOI

10.5603/CJ.2019.0017

Pubmed

30882194

Bibliographic record

Cardiol J 2019;26(1):105-108.

Authors

Grzegorz Sławiński
Ewa Lewicka
Maciej Kempa
Szymon Budrejko
Alicja Dąbrowska-Kugacka
Grzegorz Romanowicz
Grzegorz Raczak

References (8)
  1. Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009; 169(5): 463–473.
  2. Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace. 2015; 17(5): 767–777.
  3. Sławiński G, Kempa M, Lewicka E, et al. Elevated C‑reactive protein levels during cardiac implantations may increase the risk of early complications requiring transvenous lead removal: a preliminary report. Pol Arch Intern Med. 2018; 128(2): 138–140.
  4. Mahmood M, Kendi AT, Ajmal S, et al. Meta-analysis of 18F-FDG PET/CT in the diagnosis of infective endocarditis. J Nucl Cardiol. 2017 [Epub ahead of print].
  5. Burke MC, Gold MR, Knight BP, et al. Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the ide study and effortless registry. J Am Coll Cardiol. 2015; 65(16): 1605–1615.
  6. Kempa M, Budrejko S, Sławiński G, et al. Polish single-centre follow-up of subcutaneous implantable cardioverter-defibrillator (S-ICD) systems implanted for the prevention of sudden cardiac death. Kardiol Pol. 2018; 76(2): 452–458.
  7. Lee S, Souvaliotis N, Mehta D, et al. Inappropriate shock in a subcutaneous cardiac defibrillator due to residual air. Clin Case Rep. 2017; 5(8): 1203–1206.
  8. Zipse MM, Sauer WH, Varosy PD, et al. Inappropriate shocks due to subcutaneous air in a patient with a subcutaneous cardiac defibrillator. Circ Arrhythm Electrophysiol. 2014; 7(4): 768–770.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl